Privacy

XIMINO Privacy Policy

Sun Pharma is committed to ensuring the privacy of its customers. Sun Pharma will not willfully disclose any personally identifiable information about our online audience to any third party without first receiving the user's permission. We do not collect personally identifiable information from our visitors to this site other than what is voluntarily provided. We may, from time to time, use that information in an effort to identify ways to better serve our visitors' needs or contact such visitors if necessary. Visitors' IP address may be tracked for analytical purposes. Sun Pharma agrees to not disclose that information to any third party unless such intention is identified before the information is submitted or if it is required by a law enforcement agency.

By using this site, you signify your agreement to the terms and conditions of this XIMINO (minocycline hydrochloride) extended-release capsules website privacy policy. If you do not agree to these terms and conditions, please do not use the site. You have the right to ensure that your personal data is always up to date. We reserve the right, at our sole discretion, to change, modify, add, or remove portions of this policy at any time. Please check this page periodically for any changes. Your continued use of the XIMINO website following the posting of any changes to these terms shall mean that you have accepted those changes. If you wish to contact us regarding our use of your personal data, please email us at us.privacypolicy@ranbaxy.com. Requests to delete personal data will be subject to any applicable legal and ethical reporting or document filing or retention obligations imposed on us.

This privacy policy was last updated August 30, 2017. Please refer to this page from time to time to review updates to this policy.